MEI Pharma, Inc. (NASDAQ:MEIP), announced that Daniel P. Gold, Ph.D., President and Chief Executive Officer, will present at the Cowen and Company 35th Annual Health Care Conference on Wednesday, March 4, 2015 at 10:40 a.m. Eastern time from the Boston Marriott Copley Place. On Friday shares of MEI Pharma, Inc. (NASDAQ:MEIP) closed at $5.89.
On 25 February, Sunshine Heart, Inc. (NASDAQ:SSH) announced it has received unconditional approval from the FDA to conduct an interim analysis of COUNTER HF, the Company’s U.S. pivotal study. Sunshine Heart Inc. (NASDAQ:SSH) in last trading activity moved up 2.86% to close at $5.75. Company weekly performance is 9.52% while its quarterly performance stands at 26.10%. Sunshine Heart Inc. (NASDAQ:SSH) is -36.11% away from its 52 week high.
On last trading day LSI Industries Inc. (NASDAQ:LYTS) moved up 0.13% to close at $7.87. Its volatility for the week is 2.37% while volatility for the month is 3.30%. LYTS’s sales growth for past 5 years was 5.10% and its EPS growth for past 5 years was 15.60%. LSI Industries Inc. (NASDAQ:LYTS) monthly performance is 17.29%.
On 24 February, Lifetime Brands Inc. (NASDAQ:LCUT) said that it has entered into an asset purchase agreement to acquire the operating assets and assume certain liabilities of the 191-year-old Reed & Barton Corp., which recently filed for bankruptcy protection. Lifetime Brands, Inc. (NASDAQ:LCUT) has 10.00% insider ownership while its institutional ownership stands at 59.90%. In last trading activity company’s stock closed at $16.01.
On 26 February, ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) reported a net loss of $28.4 million, or $0.28 per common share, for the fourth quarter of 2014, compared to a net loss of $12.0 million, or $0.13 per common share, for the fourth quarter of 2013. The net losses for the fourth quarters of 2014 and 2013 included $4.6 million and $2.2 million, respectively, in non-cash, stock-based compensation expense. On last trading day ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) moved up 0.50% to close at $37.97. Its volatility for the week is 3.70% while volatility for the month is 3.87%. ACAD’s sales growth for past 5 years was -7.20% and its EPS growth for past 5 years was 24.00%. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) monthly performance is 21.62%.